Outcomes of Giliteritinib in R/R AML with FLT3 Positive Mutation

Speaker
Pau Montesinos
Category:
Leukemia

Speaker: Dr. Pau Montesinos

Affiliations: Attending Physician in Department of Hematology, University Hospital La Fe, Valencia, Spain

 

This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.

1
Outcomes of Giliteritinib in R/R AML with FLT3 Positive Mutation
28 minutes

Speaker: Dr. Pau Montesinos

Affiliations: Attending Physician in Department of Hematology, University Hospital La Fe, Valencia, Spain

 

This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.

2
Test your knowledge related to malignant
15 questions
Add to Wishlist
Enroll course
Enrolled: 5 students
Presentations: 1
Video: 120 minutes
eaccme

Accreditation Statement

The Hematology Live Online Education, made available on https://hematologylive.online/ and organized by Meeting Minds Experts, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

 

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMSEACCME website have formally been accredited.

 

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.